000 04174cam a2200601 i 4500
001 9780429485626
003 FlBoTFG
005 20251030122226.0
006 m o d
007 cr cnu---unuuu
008 220512s2022 xx a ob 001 0 eng d
040 _aOCoLC-P
_beng
_erda
_epn
_cOCoLC-P
020 _a9780429485626
_q(electronic bk.)
020 _a042948562X
_q(electronic bk.)
020 _a9780429939297
_q(electronic bk. ;
_qPDF)
020 _a0429939299
_q(electronic bk. ;
_qPDF)
020 _a9780429939273
_q(electronic bk. ;
_qMobipocket)
020 _a0429939272
_q(electronic bk. ;
_qMobipocket)
020 _a9780429939280
_q(electronic bk. ;
_qEPUB)
020 _a0429939280
_q(electronic bk. ;
_qEPUB)
020 _z1138594229
020 _z9781138594227
024 7 _a10.1201/9780429485626
_2doi
035 _a(OCoLC)1316708852
035 _a(OCoLC-P)1316708852
050 4 _aRS380
072 7 _aMED
_x009000
_2bisacsh
072 7 _aMED
_x071000
_2bisacsh
072 7 _aSCI
_x013000
_2bisacsh
072 7 _aTDCW
_2bicssc
245 0 0 _aBIOLOGICS AND BIOSIMILARS :
_bdrug discovery and clinical applications.
264 1 _a[Place of publication not identified] :
_bCRC Press,
_c2022.
300 _a1 online resource (1 volume) :
_billustrations (black and white, and colour)
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
520 _aBiologics and Biosimilars: Drug Discovery and Clinical Applications is a systematic integration and evaluation of all aspects of biologics and biosimilars, encompassing research and development, clinical use, global regulation, and more. Biosimilars are biological therapeutic agents designed to imitate a reference biologic with high similarities in structure, efficacy, and safety, but also with potential clinical effective and cost-efficient options for the manufacturers, payers, clinicians, and patients. Most of the top-selling prescription drugs in the current market are biologics, which have revolutionized the treatment strategies and modalities for life-threatening and/or rare diseases. This book outlines the key processes and challenges in drug development, regulations, and clinical applications of biologics, biosimilars, and even interchangeable biosimilars. Global experts in the field discuss essential categories and prototype drugs of biologics and biosimilars in clinical practice such as allergenics, blood and blood components, cell treatment, gene therapy, recombinant therapeutic proteins or peptides, tissues, and vaccines. Additional features: Integrates the latest bench and bedside evidence of drug development and regulations of biologics and biosimilars Contains key study questions for each chapter to guide the readers, as well as drug charts for all therapeutic applications of biologics and biosimilars Presents detailed schematic illustrations to explain the drug development, clinical trials, regulations, and clinical applications of biologics and biosimilars This book is an invaluable tool for health care professional students, providers, and pharmaceutical and health care industries, as well as the public, providing readers with educational updates about the drug development and clinical affairs of biological medications and their similar drugs.
588 _aOCLC-licensed vendor bibliographic record.
650 0 _aPharmaceutical biotechnology.
_965164
650 0 _aDrug development.
_984004
650 7 _aMEDICAL
_xBiotechnology.
_2bisacsh
_964066
650 7 _aMEDICAL
_xPharmacology.
_2bisacsh
_964067
650 7 _aSCIENCE
_xChemistry
_xGeneral.
_2bisacsh
_992521
700 1 _aFeng, Xiaodong,
_eeditor.
_992522
700 1 _aXie, Hong-Guang,
_eeditor.
_992523
700 1 _aMalhotra, Ashim,
_d1977-
_eeditor.
_992524
700 1 _aYang, Catherine F.,
_eeditor.
_992525
856 4 0 _3Taylor & Francis
_uhttps://www.taylorfrancis.com/books/e/9780429485626
856 4 2 _3OCLC metadata license agreement
_uhttp://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf
942 _cE-Books
999 _c67337
_d67337